Progyny, Inc. (NASDAQ:PGNY) COO Peter Anevski Sells 26,833 Shares

Progyny, Inc. (NASDAQ:PGNY) COO Peter Anevski sold 26,833 shares of the stock in a transaction dated Monday, April 5th. The shares were sold at an average price of $46.08, for a total value of $1,236,464.64. Following the completion of the sale, the chief operating officer now owns 667,079 shares of the company’s stock, valued at approximately $30,739,000.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Peter Anevski also recently made the following trade(s):

  • On Thursday, April 1st, Peter Anevski sold 800 shares of Progyny stock. The shares were sold at an average price of $46.19, for a total value of $36,952.00.
  • On Wednesday, March 10th, Peter Anevski sold 8,999 shares of Progyny stock. The shares were sold at an average price of $47.43, for a total value of $426,822.57.
  • On Wednesday, February 3rd, Peter Anevski sold 21,000 shares of Progyny stock. The shares were sold at an average price of $47.84, for a total value of $1,004,640.00.
  • On Monday, February 1st, Peter Anevski sold 21,000 shares of Progyny stock. The shares were sold at an average price of $47.93, for a total value of $1,006,530.00.

Shares of NASDAQ:PGNY opened at $44.87 on Thursday. Progyny, Inc. has a fifty-two week low of $17.90 and a fifty-two week high of $53.48. The stock has a market capitalization of $3.91 billion, a P/E ratio of 407.91 and a beta of 1.83. The business has a 50-day moving average of $46.21 and a two-hundred day moving average of $39.10.

Progyny (NASDAQ:PGNY) last posted its quarterly earnings data on Wednesday, February 24th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.01. Progyny had a return on equity of 7.43% and a net margin of 1.03%. The business had revenue of $100.30 million during the quarter. As a group, equities analysts forecast that Progyny, Inc. will post 0.14 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GW&K Investment Management LLC grew its position in Progyny by 27.3% during the 4th quarter. GW&K Investment Management LLC now owns 846,802 shares of the company’s stock worth $35,896,000 after acquiring an additional 181,412 shares during the last quarter. Strs Ohio grew its position in Progyny by 74.2% during the 3rd quarter. Strs Ohio now owns 147,900 shares of the company’s stock worth $4,352,000 after acquiring an additional 63,000 shares during the last quarter. UBS Asset Management Americas Inc. bought a new stake in Progyny during the 3rd quarter worth approximately $312,000. Weld Capital Management LLC grew its position in Progyny by 87.8% during the 3rd quarter. Weld Capital Management LLC now owns 19,939 shares of the company’s stock worth $587,000 after acquiring an additional 9,321 shares during the last quarter. Finally, Clearbridge Investments LLC lifted its holdings in Progyny by 0.4% during the 4th quarter. Clearbridge Investments LLC now owns 2,536,357 shares of the company’s stock worth $107,516,000 after buying an additional 10,135 shares in the last quarter. Institutional investors and hedge funds own 58.54% of the company’s stock.

Several brokerages have recently commented on PGNY. Zacks Investment Research lowered Progyny from a “hold” rating to a “sell” rating in a research report on Saturday, February 27th. Bank of America raised Progyny from a “neutral” rating to a “buy” rating in a report on Tuesday, March 16th. One analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $37.71.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Read More: What is included in the gross domestic product?

Insider Buying and Selling by Quarter for Progyny (NASDAQ:PGNY)

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.